anmelden
FTSE All-Share
5.526,77
PKT
+17,12
PKT
+0,31
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.04.16 | Vodafone Group overweight | JP Morgan Chase & Co. | |
| 01.04.16 | Unilever Sell | Goldman Sachs Group Inc. | |
| 01.04.16 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 31.03.16 | BT Group Equal-Weight | Morgan Stanley | |
| 31.03.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 31.03.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 31.03.16 | Unilever Sell | Goldman Sachs Group Inc. | |
| 30.03.16 | Glencore Hold | Jefferies & Company Inc. | |
| 30.03.16 | Lloyds Banking Group overweight | Morgan Stanley | |
| 30.03.16 | Barclays Equal-Weight | Morgan Stanley | |
| 30.03.16 | HSBC Underweight | Morgan Stanley | |
| 30.03.16 | Shell (ex Royal Dutch Shell) Outperform | Macquarie Research | |
| 30.03.16 | GSK buy | Citigroup Corp. | |
| 30.03.16 | Lloyds Banking Group buy | Deutsche Bank AG | |
| 30.03.16 | Imperial Brands Reduce | Nomura | |
| 30.03.16 | Lloyds Banking Group Underperform | Bernstein Research | |
| 29.03.16 | Diageo overweight | Morgan Stanley | |
| 29.03.16 | HSBC Underperform | BNP PARIBAS | |
| 29.03.16 | Diageo buy | UBS AG | |
| 29.03.16 | AstraZeneca buy | UBS AG | |
| 29.03.16 | Diageo overweight | Barclays Capital | |
| 29.03.16 | Imperial Brands Equal weight | Barclays Capital | |
| 29.03.16 | BAT overweight | Barclays Capital | |
| 24.03.16 | Prudential Outperform | BNP PARIBAS | |
| 24.03.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 23.03.16 | Sky Outperform | BNP PARIBAS | |
| 22.03.16 | BP overweight | Barclays Capital | |
| 22.03.16 | Barclays Hold | HSBC | |
| 22.03.16 | AstraZeneca Hold | HSBC | |
| 22.03.16 | Barclays Conviction Buy | Goldman Sachs Group Inc. | |
| 22.03.16 | Prudential Neutral | JP Morgan Chase & Co. | |
| 22.03.16 | Sky buy | UBS AG | |
| 21.03.16 | Glencore neutral | Morgan Stanley | |
| 21.03.16 | Rio Tinto neutral | Morgan Stanley | |
| 21.03.16 | GSK Neutral | UBS AG | |
| 21.03.16 | BP buy | Deutsche Bank AG | |
| 18.03.16 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 18.03.16 | Imperial Brands Outperform | BNP PARIBAS | |
| 18.03.16 | GSK buy | Goldman Sachs Group Inc. | |
| 18.03.16 | Rio Tinto overweight | Barclays Capital |